Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
338 participants
INTERVENTIONAL
2003-09-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
CHESS, the Comprehensive Health Enhancement Support System is an innovative technology that provides information, social support and skills training to women with breast cancer. Previous CHESS clinical trials found improved patient outcomes but little is known about what services in CHESS produce those results. This study will examine whether breast cancer patient outcomes change when conceptually distinct CHESS services (information, social support, and skills training) are systematically added to a patients treatment resources.
Primary Aims:
* Determine the relative efficacies of different types of cancer communication treatments when they are presented alone or in combination
* Determine routes or processes via which these elements work
* Determine for whom the different treatment types work best.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mentor Integration Study
NCT00468468
CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer
NCT00214162
Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care
NCT01033162
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers
NCT00365963
CHESS: Human and Computer Mentors for Prostate Cancer Patients
NCT00516256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
subjects receive internet access and computer
No interventions assigned to this group
2
CHESS informational services only
CHESS
informational services of CHESS available to subject
3
CHESS social support and informational services
CHESS
CHESS informational services and social support available to subject
4
Full CHESS
CHESS (Comprehensive Health Enhancement Support System)
Full CHESS for subject use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CHESS (Comprehensive Health Enhancement Support System)
Full CHESS for subject use
CHESS
informational services of CHESS available to subject
CHESS
CHESS informational services and social support available to subject
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All subjects must be within 2 months of their primary breast cancer diagnosis,
* All subjects must be at least 18 years of age,
* All subjects must be able to read and write English at the 6th-grade level
* Not homeless
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Baker, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Hospital
Hartford, Connecticut, United States
M. D. Anderson
Houston, Texas, United States
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Wisconsin Carbone Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1P50CA09817-01A1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CC04318
Identifier Type: OTHER
Identifier Source: secondary_id
2003-193
Identifier Type: OTHER
Identifier Source: secondary_id
A534253
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/MEDICINE/MEDICINE
Identifier Type: OTHER
Identifier Source: secondary_id
2003-193
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.